RECRUITING

Cancer Clinical Trials Financial Reimbursement Program

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To implement a Financial Reimbursement and Outreach Program at clinical sites within the Harold C. Simmons Comprehensive Cancer Center; and evaluate the impact of the program on clinical trial enrollment and demographics, as well as facilitators of and barriers to program participation.

Official Title

Enhancement of Access to and Diversity in Cancer Clinical Trials Through a Financial Reimbursement and Outreach Program

Quick Facts

Study Start:2022-07-12
Study Completion:2026-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05402033

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Be enrolled in a therapeutic cancer clinical trial
  2. * Speak English or Spanish
  1. * Not enrolled in a clinical trial
  2. * Does not speak English or Spanish

Contacts and Locations

Study Contact

Marieshia Hicks
CONTACT
214-648-7577
Marieshia.Hicks@UTSouthwestern.edu

Principal Investigator

David E Gerber, MD
PRINCIPAL_INVESTIGATOR
Professor

Study Locations (Sites)

University of Texas Southwestern Medical Center
Dallas, Texas, 75390
United States

Collaborators and Investigators

Sponsor: University of Texas Southwestern Medical Center

  • David E Gerber, MD, PRINCIPAL_INVESTIGATOR, Professor

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-12
Study Completion Date2026-06-01

Study Record Updates

Study Start Date2022-07-12
Study Completion Date2026-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer Clinical Trials